GH1 and chronic kidney disease: The findings are consistent with earlier research showing enhanced quality of life scores post GHRH plasmid therapy via electroporation in dogs and cats with chronic kidney disease (26), as well as improved psychological well-being, energy, and emotional response in adult humans with GH deficiency receiving GH replacement (32).